Pharmaceutical Industries vision to bring cure for all, need to bring medicines to market faster, and the intention to make healthcare available to all has seen trials being conducted in many locations.
The access to patients with varied gene pool, food and cultural habits and population exposed to specific diseases has seen regions like India, China, Africa, Middle East and Latin America, become major sites for sponsor companies to conduct their clinical trials. As with all global operations, operating under different regulatory guidelines, understanding different cultural and ethical values, and finding the right partners, has remained a challenge for pharmaceutical, bio – pharmaceutical and medical device companies.
Journal for Clinical Studies (JCS) with its distinguished editorial advisory board provides you with the best practice guidelines for conducting global clinical trials. We are the specialist journal providing you with relevant articles which will help you to navigate emerging markets
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.